Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001386967-11-000001
Filing Date
2011-04-06
Accepted
2011-04-06 10:34:23
Documents
1
Period of Report
2011-04-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3152
  Complete submission text file 0001386967-11-000001.txt   4840
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2200 WILSON BLVD. SUITE 102-316 ARLINGTON VA 22201
Business Address
Martell James (Reporting) CIK: 0001386967 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17263 | Film No.: 11742200